Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer
BMC Urology Dec 21, 2017
Kucukdurmaz F, et al. - The serum prolidase activity (SPA) levels were compared in males with benign prostatic hyperplasia (BPH) and prostate cancer (PCa). In BPH and PCa cases, serum prolidase activity was shown to be similar, and not associated with malondialdehyde (MDA), superoxide dismutase (SOD), or prostate-specific antigen (PSA) levels.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
